Literature DB >> 1416173

Physical and chemical properties of drug molecules governing their diffusion through the spinal meninges.

C M Bernards1, H F Hill.   

Abstract

Drugs administered into the epidural space for selective spinal analgesia must diffuse through the spinal meninges to gain access to their sites of action in the spinal cord. Therefore, knowledge of the physical and chemical properties of drug molecules that govern their diffusion through the meninges is important for understanding the pharmacokinetics of epidural analgesia. To determine the physicochemical properties of drug molecules that govern the rate at which drugs diffuse through the spinal meninges, the authors measured the permeability coefficient of eight different drug molecules through the spinal meninges of the monkey using a previously established in vitro model. We previously reported permeability measurements for four of the molecules used in this study; the other four molecules' permeability measurements are new. The measured permeability coefficient was then correlated with the drugs' molecular weight, molecular surface area, molecular volume, length of the major molecular axis, and octanol:buffer distribution coefficient. We found no relationship between the drugs' permeability coefficients and any measure of drug mass, molecular shape, or molecular size. There was, however, a biphasic relationship between the octanol: buffer distribution coefficient and the drugs' measured permeability coefficients. Drugs that were either very hydrophilic or very hydrophobic had permeability coefficients that were significantly less than drugs of intermediate hydrophobicity. These data suggest that it should be possible to design novel analgesics for which meningeal permeability is maximal.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1416173     DOI: 10.1097/00000542-199210000-00020

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  9 in total

1.  Spinal disposition and meningeal permeability of local anesthetics.

Authors:  Rozenn Clément; Jean-Marc Malinovsky; Patrice Hildgen; Gilles Dollo; Jean Pierre Estèbe; François Chevanne; Roger Le Verge; Pascal Le Corre
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

2.  Human dura mater permeability.

Authors:  C M Bernards
Journal:  Can J Anaesth       Date:  1994-11       Impact factor: 5.063

3.  Transdermal administration of morphine to healthy subjects.

Authors:  D Westerling; P Höglund; S Lundin; P Svedman
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

4.  High-frequency, low-intensity ultrasound and microbubbles enhance nerve blockade.

Authors:  Kathleen Cullion; Claudia M Santamaria; Changyou Zhan; David Zurakowski; Tao Sun; Grant L Pemberton; Nathan J McDannold; Daniel S Kohane
Journal:  J Control Release       Date:  2018-02-20       Impact factor: 9.776

5.  Epidural dexamethasone decreased inflammatory hyperalgesia and spinal cPLA₂ expression in a rat formalin test.

Authors:  Sam-Hong Min; Jung-Sub Soh; Ji-Yong Park; Sung-Uk Choi; Hye-Won Lee; Jae-Jin Lee; Jae-Hwan Kim
Journal:  Yonsei Med J       Date:  2014-11       Impact factor: 2.759

6.  Rapid fluorescence imaging of spinal cord following epidural administration of a nerve-highlighting fluorophore.

Authors:  Wanguo Liu; Rui Gu; Qingsan Zhu; Chunsheng Xiao; Lanfeng Huang; Xinming Zhuang; Jingzhe Zhang; Lidi Liu; Ben Ma; Huailin Yang; Jianchao Ma; Zhipeng Hu; Chenglin Tang; Shuhua Zhao; Xuesi Chen
Journal:  Theranostics       Date:  2017-04-10       Impact factor: 11.556

7.  Comparison between intrathecal morphine and intravenous patient control analgesia for pain control after video-assisted thoracoscopic surgery: A pilot randomized controlled study.

Authors:  Amorn Vijitpavan; Nussara Kittikunakorn; Rojnarin Komonhirun
Journal:  PLoS One       Date:  2022-04-06       Impact factor: 3.240

Review 8.  Intrathecal Drug Delivery: Advances and Applications in the Management of Chronic Pain Patient.

Authors:  Jose De Andres; Salim Hayek; Christophe Perruchoud; Melinda M Lawrence; Miguel Angel Reina; Carmen De Andres-Serrano; Ruben Rubio-Haro; Mathew Hunt; Tony L Yaksh
Journal:  Front Pain Res (Lausanne)       Date:  2022-06-16

9.  Bilirubin Oxidation Products and Cerebral Vasoconstriction.

Authors:  Robert M Rapoport
Journal:  Front Pharmacol       Date:  2018-04-27       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.